|
Jun 17
|
Exiger CMO Kody Gurfein Wins PRNews' Top Women Award
|
|
Jun 13
|
Citizens Financial, Merck, oil producers: Trending Tickers
|
|
Jun 13
|
Investors should be 'embracing volatility'
|
|
Jun 13
|
FDA Approves KEYTRUDA® (pembrolizumab) for PD-L1+ Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With Radiotherapy With or Without Cisplatin Then as a Single Agent
|
|
Jun 12
|
Merck Animal Health Receives EU CVMP Positive Opinion for NUMELVI™ (atinvicitinib) Tablets for Dogs
|
|
Jun 12
|
Merck Initiates Phase 3 Study Evaluating Dengue Vaccine Candidate
|
|
Jun 11
|
Merck’s Cholesterol Medication Achieves Primary Endpoint in Two Trials
|
|
Jun 11
|
Merck & Co (MRK) RSV Antibody for Infants Approved by US FDA
|
|
Jun 11
|
Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
|
|
Jun 11
|
JNJ vs. MRK: Which Healthcare Titan Offers Better Growth Prospects?
|
|
Jun 10
|
Merck (NYSE:MRK) Gains FDA Approval For RSV Treatment, Reports Positive Trial Results
|
|
May 29
|
Merck & Co., Inc. (MRK) Files for Global Approval of Pimicotinib After Positive Phase III TGCT Results
|
|
May 28
|
Merck (NYSE:MRK) Declares US$0.81 Dividend for Q3 2025 Payout
|
|
May 27
|
Merck Announces Third-Quarter 2025 Dividend
|
|
May 23
|
Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics
|
|
May 23
|
3 Dow Jones Stocks on Our Watchlist
|
|
May 22
|
Merck to Participate in the Bernstein 41st Annual Strategic Decisions Conference
|
|
Apr 17
|
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
|
|
Apr 16
|
Merck (NYSE:MRK) Secures Global Rights To Cyprumed's Oral Peptide Delivery Technology
|
|
Apr 16
|
Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy for Long Term Growth?
|